HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Yao Liang Tang Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Tang, Y. L. Search for Related Content PubMed PubMed Citation Articles by Tang, Y. L. Related Collections Molecular biology Related Article

---

Original Articles: Cardiovascular

Invited Commentary

Stem Cell Biology, Keck Graduate Institute, 535 Watson Dr, Claremont, CA 91711

(Email: ytang@kgi.edu).

The first 20% of the full text of this article appears below.

Myocardial ischemia is a leading cause of morbidity and mortality of elderly patients in the United States, and it can progress to end-stage heart failure. Cell transplantation with an autologous stem cell source (including myoblasts and bone marrow stem cells) can avoid the problems of host immune and inflammatory reactions, and it has been used successfully to treat acute and chronic ischemic heart diseases. Thus, stem cell therapy with autologous cells holds great promise for treating ischemic heart . . . [Full Text of this Article]

Related Article

Marrow Stromal Cells as Universal Donor Cells for Myocardial Regenerative Therapy: Their Unique Immune Tolerance

Rony Atoui, Juan-Francisco Asenjo, Minh Duong, Guangyong Chen, Ray C.-J. Chiu, and Dominique Shum-Tim
Ann. Thorac. Surg. 2008 85: 571-579. [Abstract] [Full Text] [PDF]